VeenaSusanJohnMD

PubMed

• 107 citations
  Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
  Karie Runcie, Daniel R. Budman, Veena S. John, Nagashree Seetharamu
  Molecular Medicine. 2018-09-24
• 172 citations
  Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
  Ramez N Eskander, Michael W Sill, Lindsey Beffa, Richard G Moore, Joanie M Hope
  The New England Journal of Medicine. 2023-06-08
• 5 citations
  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.
  Mary L Disis, Sarah F Adams, Jyoti Bajpai, Marcus O Butler, Tyler Curiel
  Journal for Immunotherapy of Cancer. 2023-06-01

Journal Articles

• Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer  
  Ramez N. Eskander, M.D., Michael W. Sill, Ph.D., Lindsey Beffa, M.D., Richard G. Moore, M.D., Joanie M. Hope, M.D., Fernanda B. Musa, M.D., Robert Mannel, M.D., Mark S..., NEJM, 6/8/2023
• Metastatic Malignant Ovarian Steroid Cell Tumor:A Case Report and Review of the Literature  
  Jessica Lee,1 Veena S. John,2 Sharon X. Liang,3Catherine A. D’Agostino,4 and AndrewW.Menzin5, Case Reports in Obstetrics and Gynecology, 6/2016
• Correlative In-vitro Chemotherapy Drug Resistance Assay to Clinical Response to Platinum and Taxane Chemotherapy in Ovarian Carcinoma  
  Kit L Cheng, Iuliana Shapira, Lisa Rosen, Veena John, John Lovecchio, Andrew Menzin, Jill Whyte, Lisa Dos Santos, Diana Contreras, Antoinette Sakaris, Karin Shih, Raja..., J Clin Oncol, 1/1/2013
• Percutaneous Insertion of Peritoneal Ports  
  Greben, Craig R. MD; Goldstein, Greg E. MD; Lovecchio, John MD; John, Veena MD; Putterman, Daniel MD; Caplin, Drew MD; Gandras, Eric J. MD, International Journal of Gynecological Cancer, 2/1/2012
• The Histone Deacetylase Inhibitor Panobinostat Demonstrates Marked Synergy with Conventional Chemotherapeutic Agents in Human Ovarian Cancer Cell Lines  
  Budman DR, Tai J, Calabro A, John V, Invest New Drugs, 12/1/2011
• Disparities in Referral by Risk Profile for Genetic Counseling of High-risk Individuals: A Disease-specific Analysis of Mutation Frequencies of 1,193 Patients Presenti...  
  I. Shapira, R. J. Gralla, K. S. Sultan, V. S. John, C. E. Devoe, J. T. D'Olimpio, H. Raftopoulos, L. Donahue, V. Vinciguerra, S. Cohen, J Clin Oncol, 1/1/2010
• Prevention of Mucositis in AutoBMT/stem Cell Transplant Patients  
  Klocke J, Cannon M, Devoe C, Gissinger D, John V, Bayer R L, Biology of Blood and Marrow Transplantation, 2/1/2006
• Hyperparathyroidism Accompanying Multiple Myeloma  
  Patel N, Talwar A, Donahue L, John V, Margouleff D, Clin Nucl Med, 8/1/2005
• Human Herpesvirus 6 Manifesting as Encephalitis in Hematopoietic Progenitor Cell Recipient after Reduced Intensity Allogeneic Transplantation  
  Ng N, Devoe C, John V, Bayer R, Biology of Blood and Marrow Transplantation, 2/1/2005
• Safety of Bisphosphonate Use in Hematopoietic Progenitor Cell Transplantation in Multiple Myeloma Patients  
  Mazj S, Ng N, Lichtman SM, John V, Devoe C, Bayer R L, Biology of Blood and Marrow Transplantation, 2/1/2005
• Complex Translocation (8;16;21): A New Variant of t(8;21) With t(13;22) In Acute Myeloid Leukemia  
  Gupta S, Brody J, John V, Koduru P, Am. Soc Hematol Mtg. Blood, 1/1/2005
• Role of Low-dose Heparin, Ursodiol and Glutamine in Preventing Veno-occlussive Disease of the Liver in Adults Undergoing Hematopoietic Stem Cell Ransplantation  
  Desai MR, McCreary EL, Focazio B, Devoe C, John VS, Bayer R L, Biology of Blood and Marrow Transplantation, 2/1/2004
• Clinical Evaluation of the Adverse Effects of Voriconazole in the Management of Hemopoeitic Stem Cell Transplant Patients  
  Li H, Mazj S, John V, Focazio B, Devoe C, Bayer R, Biology of Blood and Marrow Transplantation, 2/1/2004
• Safety of Rituximab following Autologous Stem Cell Transplant  
  Calderon N, John VS, Loscalzo J, Bayer R, Biology of Blood and Marrow Transplantation, 2/1/2003
• Parameters for Optimal Timing for Hematopoietic Progenitor Cell Collection  
  Kok B, John VS, Loscalzo J, Malavade V, Buchbinder A, Bayer R, Biology of Blood and Marrow Transplantation, 2/1/2003
• Allografting with Fludarabine and ATG after Failed Engraftment of Autologous Peripheral Blood Stem Cells  
  Bayer R, Focazio B, John V, Loscalzo J, Buchbinder A, Biology of Blood and Marrow Transplantation, 2/1/2003
• Harmacological Factors Influencing Anticancer Drug Selection in the Elderly  
  Veena John; Sandeep Mashru; Stuart M Lichtman, Drugs & Aging, 1/1/2003
• Join now to see all

Abstracts/Posters

• Circulating microRNA Patterns in Ovarian Cancer Increased Expression with Surgical Intervention and Chemotherapy: Stable High Presurgical "survival Pattern" (SP) miRNA...
  Iuliana Shapira, Annette Lee, Mary Keogh, Cathleen Mason, Michaela Oswald, John Lovecchio, Sharon Liang, Jill Whyte, Tawfiqul Bhuiya, Kit Cheng, Sabeen Mekan, Karen Gl..., Cancer Research, AACR 103rd Annual Meeting, Chicago, 4/15/2012
• Parent of Origin of BRCA Mutation May Determine Age at Breast Cancer Diagnosis
  Budman, Meredith Akerman, Lora Weiselberg, Vincent Vinciguerra, James D'Olimpio, Craig Devoe, Kit Ling Cheng, Laura Donahue, Veena John, Sharona Cohen, Cancer Research, Thirty-Fourth Annual CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, 12/15/2011
• Kepivance Use in Allogeneic Stem Cell Transplantation
  Bayer, R.-L., Kim, B., John, V., Devoe, C., Cannon, M., Klocke, J., Gissinger, Biology of Blood and Marrow Transplantation, D. North Shore University Hospital, Manhasset, NY, 2/1/2007

Other

• "Paclitaxel/Carboplatin with or without Sorafenib in the First-Line Treatment of Patients with Stage III/IV Epithelial Ovarian Cancer: A Randomized Phase II Study of t...